Long Term Debt Summary of Fredun Pharmaceuticals Limited

Fredun Pharmaceuticals Limited's latest annual long term debt in 2023 was 51.51 Million INR , down -89.47% from previous year.
Fredun Pharmaceuticals Limited's latest quarterly long term debt in 2024 Q1 was - INR , down -100.0% from previous quarter.
Fredun Pharmaceuticals Limited reported annual long term debt of 489.28 Million INR in 2022, up 16.39% from previous year.
Fredun Pharmaceuticals Limited reported annual long term debt of 420.39 Million INR in 2021, up 44.41% from previous year.
Fredun Pharmaceuticals Limited reported quarterly long term debt of - INR for 2023 Q1, down -100.0% from previous quarter.
Fredun Pharmaceuticals Limited reported quarterly long term debt of 127.98 Million INR for 2023 Q3, down -5.87% from previous quarter.

Annual Long Term Debt Chart of Fredun Pharmaceuticals Limited (2023 - 2010)

Historical Annual Long Term Debt of Fredun Pharmaceuticals Limited (2023 - 2010)

Year	Long Term Debt	Long Term Debt Growth
2023	51.51 Million INR	-89.47%
2022	489.28 Million INR	16.39%
2021	420.39 Million INR	44.41%
2020	291.1 Million INR	153.23%
2019	114.95 Million INR	8.05%
2018	106.39 Million INR	-15.81%
2017	126.36 Million INR	74.56%
2016	72.39 Million INR	16.89%
2015	61.92 Million INR	110.31%
2014	29.44 Million INR	46.79%
2013	20.05 Million INR	49.35%
2012	13.43 Million INR	-7.11%
2011	14.45 Million INR	-11.9%
2010	16.41 Million INR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	- INR	-100.0%
2023 Q1	- INR	-100.0%
2023 Q3	127.98 Million INR	-5.87%
2023 FY	51.51 Million INR	-89.47%
2023 Q2	135.96 Million INR	0.0%
2023 Q4	51.51 Million INR	-59.75%
2022 Q3	- INR	0.0%
2022 FY	489.28 Million INR	16.39%
2022 Q4	489.28 Million INR	0.0%
2022 Q2	- INR	0.0%
2022 Q1	- INR	-100.0%
2021 Q1	- INR	-100.0%
2021 FY	420.39 Million INR	44.41%
2021 Q2	- INR	0.0%
2021 Q3	- INR	0.0%
2021 Q4	420.39 Million INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	291.1 Million INR	153.23%
2020 Q3	- INR	-100.0%
2020 Q2	169.28 Million INR	0.0%
2020 Q4	291.1 Million INR	0.0%
2019 Q2	281.94 Million INR	0.0%
2019 Q1	- INR	-100.0%
2019 FY	114.95 Million INR	8.05%
2019 Q4	114.95 Million INR	0.0%
2019 Q3	- INR	-100.0%
2018 FY	106.39 Million INR	-15.81%
2018 Q3	- INR	-100.0%
2018 Q2	59.02 Million INR	0.0%
2018 Q4	106.39 Million INR	0.0%
2017 Q4	27.36 Million INR	0.0%
2017 FY	126.36 Million INR	74.56%
2017 Q2	82.06 Million INR	0.0%
2017 Q1	- INR	-100.0%
2016 Q3	- INR	-100.0%
2016 Q2	85.67 Million INR	0.0%
2016 FY	72.39 Million INR	16.89%
2016 Q4	72.39 Million INR	0.0%
2015 Q4	61.92 Million INR	0.0%
2015 Q1	- INR	-100.0%
2015 Q2	62.1 Million INR	0.0%
2015 FY	61.92 Million INR	110.31%
2015 Q3	- INR	-100.0%
2014 FY	29.44 Million INR	46.79%
2014 Q3	- INR	-100.0%
2014 Q2	28.46 Million INR	0.0%
2014 Q4	29.44 Million INR	0.0%
2014 Q1	- INR	-100.0%
2013 Q3	- INR	-100.0%
2013 Q4	20.05 Million INR	0.0%
2013 Q2	17.2 Million INR	0.0%
2013 FY	20.05 Million INR	49.35%
2012 FY	13.43 Million INR	-7.11%
2012 Q4	13.43 Million INR	0.0%
2011 FY	14.45 Million INR	-11.9%
2010 FY	16.41 Million INR	0.0%

Peer Long Term Debt Comparison of Fredun Pharmaceuticals Limited

Name	Long Term Debt	Long Term Debt Difference
Sunil Healthcare Limited	207.29 Million INR	75.151%
ANG Lifesciences India Limited	139.49 Million INR	63.072%
BDH Industries Limited	- INR	-Infinity%
Deccan Health Care Limited	16.77 Million INR	-207.088%
DECIPHER LABS LIMITED	- INR	-Infinity%
Gujarat Themis Biosyn Limited	12.24 Million INR	-320.601%
Hindustan Bio Sciences Limited	25.56 Million INR	-101.502%
Ishita Drugs and Industries Limited	- INR	-Infinity%
Jenburkt Pharmaceuticals Limited	- INR	-Infinity%
KIMIA BIOSCIENCES LIMITED	214.09 Million INR	75.94%
MedPlus Health Services Limited	8.68 Billion INR	99.407%
Patidar Buildcon Limited	25.32 Million INR	-103.416%
Add-Shop E-Retail Limited	5.73 Million INR	-798.657%
Bacil Pharma Limited	- INR	-Infinity%
Beryl Drugs Limited	24.03 Million INR	-114.29%
Cian Healthcare Limited	274.96 Million INR	81.266%
Concord Drugs Limited	6.45 Million INR	-698.125%
Sanjivani Paranteral Limited.	9.69 Million INR	-431.534%
Gujarat Terce Laboratories Limited	9.27 Million INR	-455.435%
Sastasundar Ventures Limited	28.65 Million INR	-79.775%
SHAMROCK INDUSTRIAL CO.LTD.	- INR	-Infinity%
Source Natural Foods and Herbal Supplements Limited	- INR	-Infinity%
SUDARSHAN PHARMA INDUSTRIES LI	104.91 Million INR	50.9%
Syschem (India) Limited	4.5 Million INR	-1044.689%
Medi-Caps Limited	- INR	-Infinity%
Parmax Pharma Limited	44.79 Million INR	-15.003%
Smruthi Organics Limited	55.61 Million INR	7.383%
Phaarmasia Limited	114 Thousand INR	-45085.088%
Transchem Limited	- INR	-Infinity%
Trinity League India Limited	- INR	-Infinity%
Tyche Industries Limited	- INR	-Infinity%
Vista Pharmaceuticals Limited	29.32 Million INR	-75.632%
Zenith Healthcare Limited	- INR	-Infinity%
Chemo Pharma Laboratories Limited	- INR	-Infinity%
Colinz Laboratories Limited	- INR	-Infinity%
Denis Chem Lab Limited	4.51 Million INR	-1040.381%
Kwality Pharmaceuticals Limited	195.6 Million INR	73.665%
Makers Laboratories Limited	90.84 Million INR	43.3%
Panchsheel Organics Limited	2.72 Million INR	-1793.787%
Parnax Lab Limited	210.53 Million INR	75.533%
PRAVEG LIMITED	595.61 Million INR	91.352%
Mercury Laboratories Limited	28.64 Million INR	-79.838%
Trident Lifeline Limited	127.99 Million INR	59.756%
Vikram Thermo (India) Limited	47.12 Million INR	-9.305%
Vivanza Biosciences Limited	26.82 Million INR	-92.062%
Zenlabs Ethica Limited	15.93 Million INR	-223.277%
SHELTER PHARMA LIMITED	5.73 Million INR	-798.657%
Vasundhara Rasayans Limited	7.89 Million INR	-552.534%
Bharat Immunologicals & Biologicals Corporation Limited	- INR	-Infinity%
Roopa Industries Limited	52.79 Million INR	2.423%
PANJON LTD.	1.41 Million INR	-3548.088%
Pharmaids Pharmaceuticals Limited	35.85 Million INR	-43.669%
TIAAN CONSUMER LIMITED	- INR	-Infinity%
Anuh Pharma Limited	3.88 Million INR	-1226.577%
Crestchem Limited	- INR	-Infinity%
Emmessar Biotech & Nutrition Limited	- INR	-Infinity%
Sandu Pharmaceuticals Limited	603 Thousand INR	-8442.454%
Trimurthi Limited	- INR	-Infinity%
Shukra Pharmaceuticals Limited	26.56 Million INR	-93.891%
Norris Medicines Limited	185.91 Million INR	72.294%
Veerhealth Care Limited	- INR	-Infinity%
Lactose (India) Limited	241.88 Million INR	78.705%
OXYGENTA PHARMACEUTICAL LIMITE	490.01 Million INR	89.488%
Ambalal Sarabhai Enterprises Limited	90.58 Million INR	43.138%
Gennex Laboratories Limited	132.16 Million INR	61.025%
Godavari Drugs Limited	111.67 Million INR	53.874%
Zenotech Laboratories Limited	- INR	-Infinity%
Shree Ganesh Remedies Limited	291.18 Million INR	82.31%
Bharat Parenterals Limited	731.62 Million INR	92.959%
Coral Laboratories Limited	- INR	-Infinity%
Evoq Remedies Limited	- INR	-Infinity%
Kerala Ayurveda Limited	594.16 Million INR	91.331%
KOBO BIOTECH LIMITED	317.14 Million INR	83.758%
Natural Capsules Limited	679.33 Million INR	92.417%
Auro Laboratories Limited	183.78 Million INR	71.972%

Global Stocks Search

Fredun Pharmaceuticals Limited (FREDUN.BO)

Long Term Debt Summary of Fredun Pharmaceuticals Limited

Annual Long Term Debt Chart of Fredun Pharmaceuticals Limited (2023 - 2010)

Historical Annual Long Term Debt of Fredun Pharmaceuticals Limited (2023 - 2010)

Peer Long Term Debt Comparison of Fredun Pharmaceuticals Limited